Avidea Merger with Vaccitech Provides New Opportunities for SNAPvax Platform
One month after being acquired in a $40 million deal by U.K.-based Vaccitech plc, the team that was formerly part of Avidea Technologies continues to advance its SNAPvax platform into the crucible of clinical trials in about one year. ...